Log in
NASDAQ:FTSV

Forty Seven Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$95.51
0.00 (0.00 %)
(As of 04/7/2020)
Add
Compare
Today's Range
$95.51
Now: $95.51
$95.51
50-Day Range
$95.51
MA: $95.51
$95.51
52-Week Range
$5.53
Now: $95.51
$95.51
VolumeN/A
Average Volume1.61 million shs
Market Capitalization$4.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.4
Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody. Forty Seven Inc. has a collaboration agreement with Genentech to include third clinical trial in non-Hodgkin's lymphoma. The company was formerly known as CD47 Sciences, Inc. Forty Seven Inc. was incorporated in 2014 and is headquartered in Menlo Park, California.
Read More
Forty Seven logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FTSV
CUSIPN/A
CIKN/A
Phone650-352-4150

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.68 million
Book Value$7.52 per share

Profitability

Net Income$-87,620,000.00

Miscellaneous

Employees57
Market Cap$4.60 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive FTSV News and Ratings via Email

Sign-up to receive the latest news and ratings for FTSV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Forty Seven (NASDAQ:FTSV) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Forty Seven?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Forty Seven in the last year. There are currently 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Forty Seven
.

How were Forty Seven's earnings last quarter?

Forty Seven Inc (NASDAQ:FTSV) released its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.38) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.38). The company had revenue of $15.68 million for the quarter, compared to the consensus estimate of $15.80 million.
View Forty Seven's earnings history
.

What price target have analysts set for FTSV?

11 brokerages have issued 12-month price targets for Forty Seven's shares. Their forecasts range from $18.00 to $95.50. On average, they anticipate Forty Seven's stock price to reach $65.95 in the next twelve months. This suggests that the stock has a possible downside of 30.9%.
View analysts' price targets for Forty Seven
.

Who are some of Forty Seven's key competitors?

What other stocks do shareholders of Forty Seven own?

Who are Forty Seven's key executives?

Forty Seven's management team includes the following people:
  • Dr. Mark A. McCamish, Pres, CEO & Director (Age 66)
  • Dr. Craig S. Gibbs, Chief Bus. Officer (Age 56)
  • Dr. Chris H. Takimoto M.D., Ph.D., Chief Medical Officer (Age 60)
  • Mr. Mark Chao, Founder & VP of Clinical Devel.
  • Mr. Jens-Peter Volkmer, Founder and VP of Research & Early Devel.

When did Forty Seven IPO?

(FTSV) raised $100 million in an IPO on Thursday, June 28th 2018. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley and Credit Suisse acted as the underwriters for the IPO and Canaccord Genuity, BTIG and Oppenheimer were co-managers.

What is Forty Seven's stock symbol?

Forty Seven trades on the NASDAQ under the ticker symbol "FTSV."

What is Forty Seven's stock price today?

One share of FTSV stock can currently be purchased for approximately $95.51.

How big of a company is Forty Seven?

Forty Seven has a market capitalization of $4.60 billion and generates $15.68 million in revenue each year. The company earns $-87,620,000.00 in net income (profit) each year or ($2.34) on an earnings per share basis. Forty Seven employs 57 workers across the globe.

What is Forty Seven's official website?

The official website for Forty Seven is www.fortyseveninc.com.

How can I contact Forty Seven?

Forty Seven's mailing address is 1490 O`BRIEN DRIVE SUITE A, MENLO PARK CA, 94025. The company can be reached via phone at 650-352-4150 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.